Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-07

Clinical Trial Update: Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trials evaluating the safety and preliminary efficacy of a topical antibacterial protein molecule applied to the nostrils in volunteers and pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antibacterial protein nasal spray (Unidentified antibacterial protein)

Snippet

Sponsor: GangaGen, Inc. | Conditions: Infectious Disease, Bacterial Infections | Phase 1, Phase 2 | Status: COMPLETED